Keywords: مهار کننده کالسینورین; Tacrolimus (TAC); Immunosuppressant; Calcineurin inhibitor; Drug delivery;
مقالات ISI مهار کننده کالسینورین (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: مهار کننده کالسینورین; immunosuppression; incidence; liver transplantation; phenotype; predictive factors; skin cancer; BCC; basal cell carcinoma; CNI; calcineurin inhibitor; KTR; kidney transplant recipient; LTR; liver transplant recipient; mTORi; mammalian target of rapamycin
Keywords: مهار کننده کالسینورین; BATF; basic leucine zipper transcription factor; BM; bone marrow; Bregs; regulatory B cells; BTLA; B and T lymphocyte attenuator; CFSE; carboxyfluorescein succinimidyl ester; CML; cell mediated lympholysis; CNI; calcineurin inhibitor; CPM; counts per minu
Keywords: مهار کننده کالسینورین; Donor-specific antibodies; Chronic active antibody-mediated rejection; Kidney transplantation; Transplant glomerulopathy; Treatment; ABMR; antibody-mediated rejection; Anti-IL2R-ab; anti-interleukin-2 receptor antibody; ATG; anti-thymocyte globulin; CAABM
Keywords: مهار کننده کالسینورین; BPAR; biopsy proven acute cellular rejection; CD; cluster of differentiation; CI; confidence interval; CNI; calcineurin inhibitor; DNA; deoxyribonucleic acid; DSA; donor-specific human leukocyte antigen alloantibody; HPA; human platelet antigen; GP; glyco
Keywords: مهار کننده کالسینورین; cardiac allograft vasculopathy; heart transplantation; immunosuppression; stem cells; tissue engineering; transplant rejection; ACR; acute cellular rejection; AMR; antibody-mediated rejection; CMR; cardiac magnetic resonance; CNI; calcineurin inhibitor; C
Keywords: مهار کننده کالسینورین; donor allocation; heart transplantation; primary graft dysfunction; rejection; sensitization; survival; ACR; acute cellular rejection; AMR; antibody-mediated rejection; BiVAD; biventricular assist device; CIN; calcineurin inhibitor; CPRA; calculated panel
Keywords: مهار کننده کالسینورین; Lupus nephritis; immunosuppression; remission; induction therapy; maintenance therapy; mycophenolate mofetil (MMF); intravenous cyclophosphamide; calcineurin inhibitor; end-stage kidney disease (ESKD); dialysis; renal failure; toxicity; adverse events; me
Keywords: مهار کننده کالسینورین; renal failure; heart transplantation; kidney transplantation; calcineurin inhibitor;
Keywords: مهار کننده کالسینورین; acute cellular rejection; Aspergillus; antibody-mediated rejection; transbronchial biopsy; bronchiolitis obliterans syndrome; pneumonia; chronic lung allograft dysfunction; lung transplant; cytomegalovirus; pulmonary graft dysfunction; immunosuppression;
Keywords: مهار کننده کالسینورین; SLE, Systemic Lupus Erythematosus; TAC, tacrolimus; MMF, mycophenolate mofetil; IVCYC, intravenous cyclophosphamide; AZA, azathioprineTacrolimus; Lupus nephritis; Systemic lupus erythematosus; Calcineurin inhibitor; Proteinuria; Cyclophosphamide
Keywords: مهار کننده کالسینورین; Magnesium; Lymphocyte; Transplantation; Hospital admission; CMV; cytomegalovirus; CNI; calcineurin inhibitor; DCD; donation after circulatory death; EBV; Epstein Barr virus; HLA; human leukocyte antigen; NK; natural killer; PCR; polymerase chain reaction;
Keywords: مهار کننده کالسینورین; ANZDATA; Australia and New Zealand Dialysis and Transplant Registry; BPAR; biopsy-proven acute rejection; CI; confidence interval; CNI; calcineurin inhibitor; CsA; cyclosporine; DSA; donor-specific antibody; HR; hazard ratio; IL-2R; interleukin 2 receptor
Keywords: مهار کننده کالسینورین; AA; African American; Alb; albumin; ACE; Angiotensin converting enzyme; ACEI; Angiotensin converting enzyme inhibitor; ARB; Angiotensin II receptor blocker; CNI; Calcineurin inhibitor; CAU; Caucasian; CAN; Chronic allograft nephropathy; CKD; Chronic kidne
Keywords: مهار کننده کالسینورین; AST; aspartate aminotransferase; BMI; body mass index; CI; confidence interval; CMV; cytomegalovirus; CNI; calcineurin inhibitor; CVA; cerebrovascular accident; DCD; donation after cardiac death; DM; diabetes mellitus; HLA; human leukocyte antigen; HTN; h
Keywords: مهار کننده کالسینورین; calcineurin inhibitor; mammalian target of rapamycin inhibitor; rapamycin; sirolimus; tacrolimus; undifferentiated carcinoma; mTOR; mammalian target of rapamycin; PI3K; phosphatidylinositol-3 kinase; PET; positron emission tomography; SCC; squamous cell c
Keywords: مهار کننده کالسینورین; Allogeneic hematopoietic stem cell transplantation; Neurologic complication; Calcineurin inhibitor; Sequelae; Prognostic factor
Keywords: مهار کننده کالسینورین; heart transplantation; race; acute rejection; mortality; calcineurin inhibitor; gene expression profile score;
Keywords: مهار کننده کالسینورین; AHR; adjusted hazard ratio; ALG; antilymphocyte globulin; ANZDATA; Australia and New Zealand Dialysis and Transplant Registry; aRR; adjusted relative risk; ATG; antithymocyte globulin; ATGAM; equine thymocyte globulin; ATS; antithymocyte serum; CI; confid
Keywords: مهار کننده کالسینورین; ACEi; angiotensin-converting enzyme inhibitor; ADR; adverse drug reaction; CCB; calcium channel blocker; CKD; chronic kidney disease; CNI; calcineurin inhibitor; eGFR; estimated glomerular filtration rate; GFR; glomerular filtration rate; NSAID; nonsteroi
Keywords: مهار کننده کالسینورین; Tacrolimus; Solid organ transplantation; Muscle toxicity; Polymyositis; Calcineurin inhibitor; T cells
Keywords: مهار کننده کالسینورین; calcineurin inhibitors; immunosuppression; mammalian target of rapamycin inhibitors; oncogenic viruses; organ transplant recipients; skin cancer; BCC; basal cell carcinoma; CI; confidence interval; CNI; calcineurin inhibitor; HPV; human papillomavirus; mT
Keywords: مهار کننده کالسینورین; NFAT; nuclear factor of activated T cells; CFSE; carboxylfluorescein diacetate succinimidyl ester; CSA; cyclosporine; PRD; prednisolone; MPA; mycophenolic acid; MMF; mycophenolate mofetil; CNI; calcineurin inhibitor; CMV; cytomegalovirus; VZV; varicella z
Keywords: مهار کننده کالسینورین; transplantation; pregnancy; calcineurin inhibitor; spirometry; renal function;
Keywords: مهار کننده کالسینورین; AIDS; acquired immunodeficiency syndrome; BCC; basal cell carcinoma; CNI; calcineurin inhibitor; EGFR; epidermal growth factor receptor; EMT; epithelial-mesenchymal transition; EV; epidermodysplasia verruciformis; HIV; human immunodeficiency virus; HPV;
Keywords: مهار کننده کالسینورین; IS; immunosuppression; CNI; calcineurin inhibitor; HCV; hepatitis C virus; RCT; randomized clinical trial; ATG; anti-thymocyte globulin; MMF; mofetil mycophenolate; mTOR; mammalian target of rapamycin; RISET; reprogramming the immune system for the establ
Keywords: مهار کننده کالسینورین; liver transplantation; kidney transplantation; chronic renal failure; calcineurin inhibitor
Treatment with mTOR inhibitors after liver transplantation enables a sustained increase in regulatory T-cells while preserving their suppressive capacity
Keywords: مهار کننده کالسینورین; mTOR inhibitor; Liver; Transplantation; Regulatory T-cells; Calcineurin inhibitor.; CD; Cluster of differentiation; CNI; Calcineurin Inhibitor; EVR; Everolimus; HCC; Hepatocellular carcinoma; MMF; Mycophenolate Mofetil; PBMC; Peripheral Blood Mononuclear
De Novo Allergy and Immune-Mediated Disorders Following Solid-Organ Transplantation-Prevalence, Natural History, and Risk Factors
Keywords: مهار کننده کالسینورین; transplantation; solid organ; liver; heart; kidney; intestine; multivisceral; allergy; autoimmunity; children; immune disorder; CNI; Calcineurin inhibitor; EBV; Epstein-Barr virus; EGID; Eosinophilic gastrointestinal disorder; HLH; Hemophagocytic lympho
Immunosuppression, Race, and Donor-Related Risk Factors Affect De novo Cancer Incidence Across Solid Organ Transplant Recipients
Keywords: مهار کننده کالسینورین; BMI; body mass index; CNI; calcineurin inhibitor; HR; hazard ratio; mTOR; mammalian target of rapamycin; SRTR; Scientific Registry of Transplant Recipients; SOT; solid organ transplant;
T-Track-CMV and QuantiFERON-CMV assays for prediction of protection from CMV reactivation in kidney transplant recipients
Keywords: مهار کننده کالسینورین; ATG; anti-thymocyte globulin; AUC; area under curve; CI; confidence interval; CMI; cell-mediated immunity; CMV; cytomegalovirus; CNI; calcineurin inhibitor; D; donor; GCV; Ganciclovir; HLA; human leukocyte antigens; KTx; kidney transplant; M; Month; MMF;
YB-1 increases glomerular, but decreases interstitial fibrosis in CNI-induced nephropathy
Keywords: مهار کننده کالسینورین; Calcineurin inhibitor; Renal fibrosis; YB-1; CNI-induced nephropathy; Subcellular shuttling; YB-1; Y-box protein-1; CNI; calcineurin inhibitor; MC; mesangial cell;
Influence of immunosuppressive drugs on the CD30 molecule in kidney transplanted patients
Keywords: مهار کننده کالسینورین; ADAM; a disintegrin and metallopeptidase; CNI; calcineurin inhibitor; DGF; delayed graft function; DSA; donor-specific antibodyies; eGFR; estimated glomerular filtration rate; EVR; everolimus; CI; confidence interval; IF/TA; interstitial fibrosis/tubular
Herpud1 impacts insulin-dependent glucose uptake in skeletal muscle cells by controlling the Ca2+-calcineurin-Akt axis
Keywords: مهار کننده کالسینورین; AdLacZ; adenovirus encoding β-galactosidase; CAIN; calcineurin inhibitor; CA-CN; constitutively-active calcineurin; CsA; cyclosporine A; [3H]-2DG; [3H]2-deoxyglucose; ER; endoplasmic reticulum; KO; knockout; Herpud1; homocysteine-inducible endoplasmic re
Achalasia in a Patient Undergoing Hematologic Stem Cell Transplant After Exposure to Tacrolimus
Keywords: مهار کننده کالسینورین; CMV; cytomegalovirus; CNI; calcineurin inhibitor; GVHD; graft-vs-host disease; HSCT; hematopoietic stem cell transplant; IV; intravenous; NO; nitric oxide; NOS; nitric oxide synthase;
ASP0028 in combination with suboptimal-dose of tacrolimus in Cynomolgus monkey renal transplantation model
Keywords: مهار کننده کالسینورین; AUC(0-24); the area under the plasma concentration-time curves from 0 to 24Â h; Cmax; the maximum plasma concentration; CNI; calcineurin inhibitor; MS; multiple sclerosis; MST; median survival time; NHPs; nonhuman primates; PD; pharmacodynamic; PK; phar
Mycophenolate mofetil is inferior to tacrolimus in sustaining remission in children with idiopathic steroid-resistant nephrotic syndrome
Keywords: مهار کننده کالسینورین; calcineurin inhibitor; focal segmental glomerulosclerosis; minimal change disease;
Use of sirolimus in pediatric heart transplant patients: A multi-institutional study from the Pediatric Heart Transplant Study Group
Keywords: مهار کننده کالسینورین; transplantation; pediatrics; drugs; sirolimus; calcineurin inhibitor; cardiac allograft vasculopathy;
Autophagy in allografts rejection: A new direction?
Keywords: مهار کننده کالسینورین; Autophagy; Transplantation; Allograft; T lymphocyte; Tolerance; TCR; T cell receptor; I/R; Ischemia-reperfusion; PI3K; Phosphatidylinosito 3-kinase; mTOR; Mammalian target of rapamycin; CNI; Calcineurin inhibitor;
Wound complications and surgical events in de novo heart transplant patients treated with everolimus: Post-hoc analysis of the SCHEDULE trial
Keywords: مهار کننده کالسینورین; AE; adverse event; AZA; azathioprine; BMI; body mass index; CAV; cardiac allograft vasculopathy; CNI; calcineurin inhibitor; CyA; cyclosporine A; DM; diabetes mellitus; EVE; everolimus; HTx; heart transplant; ISHLT; International Society of Heart and Lung
Epidermal Desmoglein 1 Expression Is Reduced in Kidney Transplant Recipients Compared with Immunocompetent Patients
Keywords: مهار کننده کالسینورین; CNI; calcineurin inhibitor; Dsg; desmoglein; ICP; immunocompetent patient; KTR; kidney transplant recipient; SSC; squamous cell carcinoma;
14-bp ins/del polymorphism and +3142C>G SNP of the HLA-G gene have a significant impact on acute rejection after liver transplantation
Keywords: مهار کننده کالسینورین; APC; antigen presenting cell; bp; base pair; C; cytosine; CD; cluster of differentiation; CI; confidence interval; CNI; calcineurin inhibitor; del; deletion; G; guanine; HBV; Hepatitis B Virus; HCC; Hepatocellular Carcinoma; HCV; Hepatitis C Virus; HLA-G;
'De novo' and 'recurrent' autoimmune hepatitis after liver transplantation: A comprehensive review
Keywords: مهار کننده کالسینورین; Liver allograft dysfunction; Autoimmunity; Molecular mimicry; Immunosuppression; Outcomes; dn-AIH; de novo autoimmune hepatitis; LT; liver transplantation; CNI; calcineurin inhibitor; GSTT1; glutathione s-transferase T1;
Research ArticleCounter-regulation of rejection activity against human liver grafts by donor PD-L1 and recipient PD-1 interaction
Keywords: مهار کننده کالسینورین; CFSE; carboxyfluorescein succinimidyl ester; CNI; calcineurin inhibitor; CTLA-4; cytotoxic T lymphocyte antigen 4; DC; dendritic cell; HWE; Hardy Weinberg Equilibrium; LT; liver transplantation; PBMC; peripheral blood mononuclear cells; PD-1; programmed d
Calcineurin inhibitors impair neutrophil activity against Aspergillus fumigatus in allogeneic hematopoietic stem cell transplant recipients
Keywords: مهار کننده کالسینورین; Innate immunity; calcineurin inhibitor; invasive fungal infection; immune reconstitution; transplantation; CD62L; CD62 ligand; GvHD; Graft-versus-host disease; HSCT; Hematopoietic stem cell transplant; NET; Neutrophil extracellular trap; ROS; Reactive oxy
De novo cancer avoidance after renal transplantation: A case–control study on low-dose sirolimus combined with a calcineurin inhibitor
Keywords: مهار کننده کالسینورین; calcineurin inhibitor; malignancy; renal transplantation; sirolimus
Dexamethasone but not tacrolimus suppresses TNF-α-induced thymic stromal lymphopoietin expression in lesional keratinocytes of atopic dermatitis model
Keywords: مهار کننده کالسینورین; Thymic stromal lymphopoietin; Atopic dermatitis; Glucocorticosteroid; Calcineurin inhibitor; Tumor necrosis factor-α; Psoriasis;
Preventive administration of UDCA after liver transplantation for primary biliary cirrhosis is associated with a lower risk of disease recurrence
Keywords: مهار کننده کالسینورین; Prophylaxis; Risk factors; UDCA; Calcineurin inhibitor; Immunosuppression; Liver biopsy; Survival
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantation
Keywords: مهار کننده کالسینورین; BPAR; biopsy-proven acute rejection; CAV; cardiac allograft vasculopathy; CMV; cytomegalovirus; CNI; calcineurin inhibitor; CsA; cyclosporine; eGFR; estimated glomerular filtration rate; IVUS; intravascular ultrasound; LVAD; left ventricular assist device
EASL Clinical Practice Guidelines: Autoimmune hepatitis
Keywords: مهار کننده کالسینورین; ACG; American College of Gastroenterology; AGA; American Gastroenterological Association; ANCA; Antineutrophil cytoplasmic antibodies; APECED; Autoimmune polyendocrinopathy-cadidiasis ectodermal dystrophy; AS; acute severe autoimmune; CNI; Calcineurin inh